Sex differences in in vivo tau neuropathology in a multiethnic sample of late middle-aged adults
- PMID: 33894641
- PMCID: PMC8178209
- DOI: 10.1016/j.neurobiolaging.2021.03.007
Sex differences in in vivo tau neuropathology in a multiethnic sample of late middle-aged adults
Abstract
It is unclear whether women have higher brain tau pathology. The objective of this study was to examine whether women have higher tau burden than men, and whether tau differences are independent of amyloid β (Aβ) burden. We conducted a cross-sectional analysis of a multiethnic sample of 252 nondemented late middle-aged (mean age: 64.1 years) adults with tau and amyloid Positron Emission Tomography (PET) data. Tau burden was measured as global standardized uptake value ratio (SUVR) in the middle/inferior temporal gyri and medial temporal cortex with 18F-MK-6240 PET. Aβ was measured as global SUVR with 18F-Florbetaben PET. Women had higher middle/inferior temporal gyri tau SUVR compared to men. However, no sex differences in the medial temporal cortex were observed. Women had higher brain Aβ SUVR compared to men. Continuous Aβ SUVR was positively correlated with medial temporal cortex and middle/inferior temporal gyri tau SUVR. However, there was no evidence of effect modification by Aβ SUVR on sex and tau. Compared with men, women in late middle age show higher tau burden, independent of Aβ.
Keywords: Alzheimer's disease; Epidemiology; Neuroimaging; Sex differences.
Copyright © 2021. Published by Elsevier Inc.
Conflict of interest statement
Conflict of Interest/Disclosures
JA Luchsinger receives a stipend from Wolters Kluwer, N.V. as Editor in Chief of the journal
Figures
Similar articles
-
Region-Specific Association of Subjective Cognitive Decline With Tauopathy Independent of Global β-Amyloid Burden.JAMA Neurol. 2017 Dec 1;74(12):1455-1463. doi: 10.1001/jamaneurol.2017.2216. JAMA Neurol. 2017. PMID: 28973551 Free PMC article.
-
Sex Differences in in vivo Alzheimer's Disease Neuropathology in Late Middle-Aged Hispanics.J Alzheimers Dis. 2020;74(4):1243-1252. doi: 10.3233/JAD-191183. J Alzheimers Dis. 2020. PMID: 32250303 Free PMC article.
-
Sex Differences in the Association of Global Amyloid and Regional Tau Deposition Measured by Positron Emission Tomography in Clinically Normal Older Adults.JAMA Neurol. 2019 May 1;76(5):542-551. doi: 10.1001/jamaneurol.2018.4693. JAMA Neurol. 2019. PMID: 30715078 Free PMC article.
-
Association of APOE4 and Clinical Variability in Alzheimer Disease With the Pattern of Tau- and Amyloid-PET.Neurology. 2021 Feb 2;96(5):e650-e661. doi: 10.1212/WNL.0000000000011270. Epub 2020 Dec 1. Neurology. 2021. PMID: 33262228 Free PMC article.
-
Longitudinal 18F-MK-6240 tau tangles accumulation follows Braak stages.Brain. 2021 Dec 16;144(11):3517-3528. doi: 10.1093/brain/awab248. Brain. 2021. PMID: 34515754 Free PMC article.
Cited by
-
Explaining variability in early stages of [18F]-flortaucipir tau-PET binding: Focus on sex differences.Alzheimers Dement (Amst). 2024 Mar 7;16(1):e12565. doi: 10.1002/dad2.12565. eCollection 2024 Jan-Mar. Alzheimers Dement (Amst). 2024. PMID: 38463040 Free PMC article.
-
Minding the Gap: Exploring Neuroinflammatory and Microglial Sex Differences in Alzheimer's Disease.Int J Mol Sci. 2023 Dec 12;24(24):17377. doi: 10.3390/ijms242417377. Int J Mol Sci. 2023. PMID: 38139206 Free PMC article. Review.
-
Sex and Sleep Disruption as Contributing Factors in Alzheimer's Disease.J Alzheimers Dis. 2024;97(1):31-74. doi: 10.3233/JAD-230527. J Alzheimers Dis. 2024. PMID: 38007653 Free PMC article. Review.
-
Contribution of extracerebral tracer retention and partial volume effects to sex differences in Flortaucipir-PET signal.J Cereb Blood Flow Metab. 2024 Jan;44(1):131-141. doi: 10.1177/0271678X231196978. Epub 2023 Sep 20. J Cereb Blood Flow Metab. 2024. PMID: 37728659
-
Age-, sex-, and pathology-related variability in brain structure and cognition.Transl Psychiatry. 2023 Aug 14;13(1):278. doi: 10.1038/s41398-023-02572-6. Transl Psychiatry. 2023. PMID: 37574523 Free PMC article.
References
-
- Barnes LL, Wilson RS, Bienias JL, Schneider JA, Evans DA, Bennett DA, 2005. Sex differences in the clinical manifestations of Alzheimer disease pathology. Arch Gen Psychiatry 62(6), 685–691. - PubMed
-
- Betthauser TJ, Cody KA, Zammit MD, Murali D, Converse AK, Barnhart TE, Stone CK, Rowley HA, Johnson SC, Christian BT, 2019. In Vivo Characterization and Quantification of Neurofibrillary Tau PET Radioligand 18F-MK-6240 in Humans from Alzheimer Disease Dementia to Young Controls. Journal of nuclear medicine : official publication, Society of Nuclear Medicine 60(1), 93–99. - PMC - PubMed
-
- Betthauser TJ, Koscik RL, Jonaitis EM, Allison SL, Cody KA, Erickson CM, Rowley HA, Stone CK, Mueller KD, Clark LR, Carlsson CM, Chin NA, Asthana S, Christian BT, Johnson SC, 2020. Amyloid and tau imaging biomarkers explain cognitive decline from late middle-age. Brain 143(1), 320–335. - PMC - PubMed
-
- Braak H, Del Tredici K, 2015. The preclinical phase of the pathological process underlying sporadic Alzheimer’s disease. Brain 138(Pt 10), 2814–2833. - PubMed
-
- Buckley RF, Mormino EC, Rabin JS, Hohman TJ, Landau S, Hanseeuw BJ, Jacobs HIL, Papp KV, Amariglio RE, Properzi MJ, Schultz AP, Kirn D, Scott MR, Hedden T, Farrell M, Price J, Chhatwal J, Rentz DM, Villemagne VL, Johnson KA, Sperling RA, 2019. Sex Differences in the Association of Global Amyloid and Regional Tau Deposition Measured by Positron Emission Tomography in Clinically Normal Older Adults. JAMA Neurol 76(5), 542–551. - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
